Tumor lysis syndrome: risk factors and treatment


Tumor lysis syndrome is a typical oncological complication, characterized by hyperuricemia, hyperkalemia, hyperphosphatemia with secondary hypocalcemia, acidosis and acute renal failure. It occurs particularly in patients with lymphoproliferative diseases during therapy with potent myelosuppressive substances. Patients with solid tumors rarely develop a… (More)
DOI: 10.1007/s00508-005-0318-y


Cite this paper

@article{Hrl2005TumorLS, title={Tumor lysis syndrome: risk factors and treatment}, author={Walter Hermann H{\"o}rl}, journal={Wiener klinische Wochenschrift}, year={2005}, volume={117}, pages={7-17} }